nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.455	1	CpDpCtD
Fludrocortisone—AR—type 2 diabetes mellitus	0.231	0.596	CbGaD
Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.156	0.404	CbGaD
Fludrocortisone—AR—penis—type 2 diabetes mellitus	0.00319	0.226	CbGeAlD
Fludrocortisone—NR3C1—nerve—type 2 diabetes mellitus	0.00106	0.0751	CbGeAlD
Fludrocortisone—NR3C2—retina—type 2 diabetes mellitus	0.00082	0.058	CbGeAlD
Fludrocortisone—NR3C2—nephron tubule—type 2 diabetes mellitus	0.000773	0.0546	CbGeAlD
Fludrocortisone—NR3C2—cardiovascular system—type 2 diabetes mellitus	0.000694	0.0491	CbGeAlD
Fludrocortisone—NR3C2—kidney—type 2 diabetes mellitus	0.000679	0.048	CbGeAlD
Fludrocortisone—NR3C2—cortex of kidney—type 2 diabetes mellitus	0.000661	0.0468	CbGeAlD
Fludrocortisone—NR3C2—adipose tissue—type 2 diabetes mellitus	0.000612	0.0433	CbGeAlD
Fludrocortisone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000515	0.0364	CbGeAlD
Fludrocortisone—AR—cardiovascular system—type 2 diabetes mellitus	0.000514	0.0363	CbGeAlD
Fludrocortisone—AR—kidney—type 2 diabetes mellitus	0.000503	0.0356	CbGeAlD
Fludrocortisone—AR—cortex of kidney—type 2 diabetes mellitus	0.00049	0.0346	CbGeAlD
Fludrocortisone—AR—adipose tissue—type 2 diabetes mellitus	0.000453	0.032	CbGeAlD
Fludrocortisone—NR3C2—liver—type 2 diabetes mellitus	0.000429	0.0303	CbGeAlD
Fludrocortisone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000414	0.0293	CbGeAlD
Fludrocortisone—Contusion—Metformin—type 2 diabetes mellitus	0.000408	0.00419	CcSEcCtD
Fludrocortisone—Erythema—Tolazamide—type 2 diabetes mellitus	0.000405	0.00417	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Rosiglitazone—type 2 diabetes mellitus	0.000398	0.00409	CcSEcCtD
Fludrocortisone—Glycosuria—Losartan—type 2 diabetes mellitus	0.00039	0.00401	CcSEcCtD
Fludrocortisone—Erythema—Acarbose—type 2 diabetes mellitus	0.00039	0.00401	CcSEcCtD
Fludrocortisone—Oesophagitis—Gliclazide—type 2 diabetes mellitus	0.000389	0.004	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Gliclazide—type 2 diabetes mellitus	0.000387	0.00398	CcSEcCtD
Fludrocortisone—Neoplasm—Gliclazide—type 2 diabetes mellitus	0.000384	0.00395	CcSEcCtD
Fludrocortisone—Vascular purpura—Glyburide—type 2 diabetes mellitus	0.000384	0.00395	CcSEcCtD
Fludrocortisone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000377	0.0892	CrCbGaD
Fludrocortisone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000372	0.0263	CbGeAlD
Fludrocortisone—Vertigo—Tolazamide—type 2 diabetes mellitus	0.000364	0.00375	CcSEcCtD
Fludrocortisone—NR3C1—kidney—type 2 diabetes mellitus	0.000364	0.0258	CbGeAlD
Fludrocortisone—Abdominal distension—Glimepiride—type 2 diabetes mellitus	0.000363	0.00373	CcSEcCtD
Fludrocortisone—NR3C1—pancreas—type 2 diabetes mellitus	0.000362	0.0256	CbGeAlD
Fludrocortisone—Purpura—Glyburide—type 2 diabetes mellitus	0.000357	0.00367	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.000357	0.00367	CcSEcCtD
Fludrocortisone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000355	0.0251	CbGeAlD
Fludrocortisone—Pancreatitis—Sitagliptin—type 2 diabetes mellitus	0.000352	0.00362	CcSEcCtD
Fludrocortisone—Sweating increased—Glimepiride—type 2 diabetes mellitus	0.000351	0.00361	CcSEcCtD
Fludrocortisone—Neoplasm—Orlistat—type 2 diabetes mellitus	0.000349	0.00359	CcSEcCtD
Fludrocortisone—Myalgia—Linagliptin—type 2 diabetes mellitus	0.000342	0.00351	CcSEcCtD
Fludrocortisone—Injury—Gliclazide—type 2 diabetes mellitus	0.000336	0.00345	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Pioglitazone—type 2 diabetes mellitus	0.000334	0.00343	CcSEcCtD
Fludrocortisone—Cataract—Losartan—type 2 diabetes mellitus	0.000332	0.00341	CcSEcCtD
Fludrocortisone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000328	0.0232	CbGeAlD
Fludrocortisone—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000328	0.00337	CcSEcCtD
Fludrocortisone—Infection—Linagliptin—type 2 diabetes mellitus	0.000325	0.00335	CcSEcCtD
Fludrocortisone—Erythema—Repaglinide—type 2 diabetes mellitus	0.000325	0.00334	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Sitagliptin—type 2 diabetes mellitus	0.000324	0.00333	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Orlistat—type 2 diabetes mellitus	0.000322	0.00331	CcSEcCtD
Fludrocortisone—Oedema—Acarbose—type 2 diabetes mellitus	0.000318	0.00327	CcSEcCtD
Fludrocortisone—AR—liver—type 2 diabetes mellitus	0.000318	0.0225	CbGeAlD
Fludrocortisone—Oesophagitis—Irbesartan—type 2 diabetes mellitus	0.000307	0.00316	CcSEcCtD
Fludrocortisone—Ecchymosis—Irbesartan—type 2 diabetes mellitus	0.000304	0.00312	CcSEcCtD
Fludrocortisone—Abdominal distension—Glyburide—type 2 diabetes mellitus	0.000299	0.00308	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Linagliptin—type 2 diabetes mellitus	0.000298	0.00307	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000296	0.00305	CcSEcCtD
Fludrocortisone—Pancreatitis—Glyburide—type 2 diabetes mellitus	0.000291	0.003	CcSEcCtD
Fludrocortisone—Sweating increased—Glyburide—type 2 diabetes mellitus	0.000289	0.00298	CcSEcCtD
Fludrocortisone—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.000289	0.00297	CcSEcCtD
Fludrocortisone—Ecchymosis—Losartan—type 2 diabetes mellitus	0.000286	0.00294	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.000284	0.0672	CrCbGaD
Fludrocortisone—Injury—Metformin—type 2 diabetes mellitus	0.000281	0.00289	CcSEcCtD
Fludrocortisone—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000281	0.00289	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Irbesartan—type 2 diabetes mellitus	0.00028	0.00288	CcSEcCtD
Fludrocortisone—Erythema—Glipizide—type 2 diabetes mellitus	0.000269	0.00277	CcSEcCtD
Fludrocortisone—Abdominal distension—Gliclazide—type 2 diabetes mellitus	0.000269	0.00276	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000265	0.00273	CcSEcCtD
Fludrocortisone—Oedema—Repaglinide—type 2 diabetes mellitus	0.000265	0.00273	CcSEcCtD
Fludrocortisone—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000265	0.00273	CcSEcCtD
Fludrocortisone—Injury—Irbesartan—type 2 diabetes mellitus	0.000265	0.00273	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Losartan—type 2 diabetes mellitus	0.000264	0.00271	CcSEcCtD
Fludrocortisone—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.000263	0.0027	CcSEcCtD
Fludrocortisone—Urticaria—Tolazamide—type 2 diabetes mellitus	0.000263	0.0027	CcSEcCtD
Fludrocortisone—Myalgia—Rosiglitazone—type 2 diabetes mellitus	0.000262	0.00269	CcSEcCtD
Fludrocortisone—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00026	0.00268	CcSEcCtD
Fludrocortisone—Vascular purpura—Losartan—type 2 diabetes mellitus	0.000256	0.00264	CcSEcCtD
Fludrocortisone—Urticaria—Acarbose—type 2 diabetes mellitus	0.000253	0.0026	CcSEcCtD
Fludrocortisone—Erythema—Glimepiride—type 2 diabetes mellitus	0.000251	0.00258	CcSEcCtD
Fludrocortisone—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.000251	0.00258	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000251	0.00258	CcSEcCtD
Fludrocortisone—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.00025	0.00257	CcSEcCtD
Fludrocortisone—Injury—Losartan—type 2 diabetes mellitus	0.00025	0.00257	CcSEcCtD
Fludrocortisone—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000249	0.00256	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Ramipril—type 2 diabetes mellitus	0.000246	0.00253	CcSEcCtD
Fludrocortisone—Abdominal distension—Orlistat—type 2 diabetes mellitus	0.000244	0.00251	CcSEcCtD
Fludrocortisone—Urticaria—Nateglinide—type 2 diabetes mellitus	0.000244	0.00251	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.000242	0.00249	CcSEcCtD
Fludrocortisone—Vertigo—Glipizide—type 2 diabetes mellitus	0.000242	0.00249	CcSEcCtD
Fludrocortisone—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000241	0.00248	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.000241	0.00248	CcSEcCtD
Fludrocortisone—Affect lability—Irbesartan—type 2 diabetes mellitus	0.00024	0.00247	CcSEcCtD
Fludrocortisone—Purpura—Losartan—type 2 diabetes mellitus	0.000238	0.00245	CcSEcCtD
Fludrocortisone—Pancreatitis—Orlistat—type 2 diabetes mellitus	0.000237	0.00244	CcSEcCtD
Fludrocortisone—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000237	0.00244	CcSEcCtD
Fludrocortisone—Sweating increased—Orlistat—type 2 diabetes mellitus	0.000236	0.00243	CcSEcCtD
Fludrocortisone—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000234	0.00241	CcSEcCtD
Fludrocortisone—Hypertension—Glipizide—type 2 diabetes mellitus	0.000232	0.00239	CcSEcCtD
Fludrocortisone—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00238	CcSEcCtD
Fludrocortisone—Mood swings—Irbesartan—type 2 diabetes mellitus	0.000231	0.00237	CcSEcCtD
Fludrocortisone—NR3C1—liver—type 2 diabetes mellitus	0.00023	0.0163	CbGeAlD
Fludrocortisone—Myalgia—Glipizide—type 2 diabetes mellitus	0.000229	0.00236	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000229	0.00235	CcSEcCtD
Fludrocortisone—Headache—Tolbutamide—type 2 diabetes mellitus	0.000228	0.00234	CcSEcCtD
Fludrocortisone—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000226	0.00232	CcSEcCtD
Fludrocortisone—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00231	CcSEcCtD
Fludrocortisone—Abdominal distension—Metformin—type 2 diabetes mellitus	0.000225	0.00231	CcSEcCtD
Fludrocortisone—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00229	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000222	0.00521	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—NR3C1—type 2 diabetes mellitus	0.00022	0.00518	CbGpPWpGaD
Fludrocortisone—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00022	0.00226	CcSEcCtD
Fludrocortisone—Vascular purpura—Ramipril—type 2 diabetes mellitus	0.00022	0.00226	CcSEcCtD
Fludrocortisone—Oedema—Glipizide—type 2 diabetes mellitus	0.00022	0.00226	CcSEcCtD
Fludrocortisone—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.000219	0.00226	CcSEcCtD
Fludrocortisone—Pancreatitis—Metformin—type 2 diabetes mellitus	0.000219	0.00225	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—APOB—type 2 diabetes mellitus	0.000218	0.00512	CbGpPWpGaD
Fludrocortisone—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000218	0.00224	CcSEcCtD
Fludrocortisone—Sweating increased—Metformin—type 2 diabetes mellitus	0.000217	0.00224	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000217	0.00511	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000217	0.0051	CbGpPWpGaD
Fludrocortisone—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000217	0.00223	CcSEcCtD
Fludrocortisone—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00222	CcSEcCtD
Fludrocortisone—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.000215	0.00221	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000214	0.00504	CbGpPWpGaD
Fludrocortisone—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00219	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000212	0.00218	CcSEcCtD
Fludrocortisone—Abdominal distension—Irbesartan—type 2 diabetes mellitus	0.000212	0.00218	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.000211	0.00496	CbGpPWpGaD
Fludrocortisone—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000211	0.00217	CcSEcCtD
Fludrocortisone—Oedema—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00216	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00216	CcSEcCtD
Fludrocortisone—Infection—Pioglitazone—type 2 diabetes mellitus	0.000209	0.00215	CcSEcCtD
Fludrocortisone—Headache—Tolazamide—type 2 diabetes mellitus	0.000207	0.00213	CcSEcCtD
Fludrocortisone—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000207	0.00213	CcSEcCtD
Fludrocortisone—Erythema—Glyburide—type 2 diabetes mellitus	0.000207	0.00213	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000207	0.00486	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Irbesartan—type 2 diabetes mellitus	0.000207	0.00212	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000206	0.00485	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000206	0.00485	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000205	0.00483	CbGpPWpGaD
Fludrocortisone—Headache—Linagliptin—type 2 diabetes mellitus	0.000205	0.00211	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000205	0.00211	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000204	0.0021	CcSEcCtD
Fludrocortisone—Purpura—Ramipril—type 2 diabetes mellitus	0.000204	0.0021	CcSEcCtD
Fludrocortisone—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00209	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00209	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.000203	0.00209	CcSEcCtD
Fludrocortisone—Infection—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00209	CcSEcCtD
Fludrocortisone—Muscular weakness—Losartan—type 2 diabetes mellitus	0.000202	0.00208	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.0002	0.00471	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.0002	0.00206	CcSEcCtD
Fludrocortisone—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000199	0.00205	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000199	0.00468	CbGpPWpGaD
Fludrocortisone—Insomnia—Glipizide—type 2 diabetes mellitus	0.000199	0.00204	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000198	0.00204	CcSEcCtD
Fludrocortisone—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000197	0.00203	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000197	0.00464	CbGpPWpGaD
Fludrocortisone—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00202	CcSEcCtD
Fludrocortisone—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000196	0.00202	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000196	0.00461	CbGpPWpGaD
Fludrocortisone—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00201	CcSEcCtD
Fludrocortisone—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000196	0.00201	CcSEcCtD
Fludrocortisone—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000195	0.002	CcSEcCtD
Fludrocortisone—Pancreatitis—Losartan—type 2 diabetes mellitus	0.000194	0.002	CcSEcCtD
Fludrocortisone—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000194	0.00199	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000194	0.00456	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000192	0.00197	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.00019	0.00447	CbGpPWpGaD
Fludrocortisone—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00019	0.00196	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.00019	0.00195	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000189	0.00445	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000188	0.00442	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000186	0.00191	CcSEcCtD
Fludrocortisone—Erythema—Gliclazide—type 2 diabetes mellitus	0.000186	0.00191	CcSEcCtD
Fludrocortisone—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000185	0.00191	CcSEcCtD
Fludrocortisone—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000185	0.0019	CcSEcCtD
Fludrocortisone—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000185	0.0019	CcSEcCtD
Fludrocortisone—Infection—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00189	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000183	0.00431	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000183	0.00431	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.00018	0.00424	CbGpPWpGaD
Fludrocortisone—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00018	0.00185	CcSEcCtD
Fludrocortisone—Convulsion—Glyburide—type 2 diabetes mellitus	0.000179	0.00185	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000179	0.00184	CcSEcCtD
Fludrocortisone—Myalgia—Glyburide—type 2 diabetes mellitus	0.000176	0.00181	CcSEcCtD
Fludrocortisone—Urticaria—Glipizide—type 2 diabetes mellitus	0.000174	0.00179	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR3C1—type 2 diabetes mellitus	0.000174	0.00409	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3R1—type 2 diabetes mellitus	0.000173	0.00406	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000171	0.00401	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.00017	0.00399	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—type 2 diabetes mellitus	0.000169	0.00398	CbGpPWpGaD
Fludrocortisone—Oedema—Glyburide—type 2 diabetes mellitus	0.000169	0.00174	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—NR3C1—type 2 diabetes mellitus	0.000169	0.00397	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000168	0.00396	CbGpPWpGaD
Fludrocortisone—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00172	CcSEcCtD
Fludrocortisone—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000167	0.00172	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—type 2 diabetes mellitus	0.000167	0.00393	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000167	0.00171	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000166	0.00391	CbGpPWpGaD
Fludrocortisone—Headache—Repaglinide—type 2 diabetes mellitus	0.000166	0.00171	CcSEcCtD
Fludrocortisone—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000166	0.0017	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000163	0.00168	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000163	0.00384	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000163	0.00383	CbGpPWpGaD
Fludrocortisone—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000163	0.00167	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000163	0.00383	CbGpPWpGaD
Fludrocortisone—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00167	CcSEcCtD
Fludrocortisone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000162	0.00166	CcSEcCtD
Fludrocortisone—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000161	0.00166	CcSEcCtD
Fludrocortisone—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000161	0.00165	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.00016	0.00376	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000158	0.00372	CbGpPWpGaD
Fludrocortisone—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000158	0.00163	CcSEcCtD
Fludrocortisone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000158	0.00162	CcSEcCtD
Fludrocortisone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000157	0.00162	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000157	0.00368	CbGpPWpGaD
Fludrocortisone—Erythema—Metformin—type 2 diabetes mellitus	0.000156	0.0016	CcSEcCtD
Fludrocortisone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000155	0.00159	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—type 2 diabetes mellitus	0.000154	0.00363	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000154	0.00158	CcSEcCtD
Fludrocortisone—Vertigo—Valsartan—type 2 diabetes mellitus	0.000153	0.00158	CcSEcCtD
Fludrocortisone—Vertigo—Orlistat—type 2 diabetes mellitus	0.000152	0.00156	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000151	0.00356	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000151	0.00355	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Fludrocortisone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Fludrocortisone—Infection—Gliclazide—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Fludrocortisone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00015	0.00155	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—INS—type 2 diabetes mellitus	0.000149	0.0035	CbGpPWpGaD
Fludrocortisone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Fludrocortisone—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Fludrocortisone—Erythema—Irbesartan—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Fludrocortisone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000147	0.00151	CcSEcCtD
Fludrocortisone—Convulsion—Orlistat—type 2 diabetes mellitus	0.000146	0.0015	CcSEcCtD
Fludrocortisone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000145	0.0015	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000145	0.00341	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000144	0.00339	CbGpPWpGaD
Fludrocortisone—Myalgia—Orlistat—type 2 diabetes mellitus	0.000144	0.00148	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000143	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000141	0.00331	CbGpPWpGaD
Fludrocortisone—Oedema—Valsartan—type 2 diabetes mellitus	0.000139	0.00143	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000139	0.00143	CcSEcCtD
Fludrocortisone—Infection—Valsartan—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fludrocortisone—Erythema—Losartan—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fludrocortisone—Oedema—Orlistat—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fludrocortisone—Headache—Glipizide—type 2 diabetes mellitus	0.000138	0.00141	CcSEcCtD
Fludrocortisone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000137	0.00322	CbGpPWpGaD
Fludrocortisone—Infection—Orlistat—type 2 diabetes mellitus	0.000137	0.00141	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000135	0.00317	CbGpPWpGaD
Fludrocortisone—Hypertension—Metformin—type 2 diabetes mellitus	0.000134	0.00138	CcSEcCtD
Fludrocortisone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000134	0.00138	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000133	0.00137	CcSEcCtD
Fludrocortisone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000133	0.00136	CcSEcCtD
Fludrocortisone—Myalgia—Metformin—type 2 diabetes mellitus	0.000132	0.00136	CcSEcCtD
Fludrocortisone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000132	0.00136	CcSEcCtD
Fludrocortisone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000132	0.00136	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000131	0.00307	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000129	0.00304	CbGpPWpGaD
Fludrocortisone—Headache—Glimepiride—type 2 diabetes mellitus	0.000128	0.00132	CcSEcCtD
Fludrocortisone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000128	0.00132	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000128	0.003	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SRC—type 2 diabetes mellitus	0.000128	0.003	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Fludrocortisone—Oedema—Metformin—type 2 diabetes mellitus	0.000127	0.00131	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000127	0.00298	CbGpPWpGaD
Fludrocortisone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Fludrocortisone—Infection—Metformin—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Fludrocortisone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SIRT1—type 2 diabetes mellitus	0.000126	0.00296	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000125	0.00129	CcSEcCtD
Fludrocortisone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000125	0.00129	CcSEcCtD
Fludrocortisone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000125	0.00128	CcSEcCtD
Fludrocortisone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Fludrocortisone—Vertigo—Losartan—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000124	0.00291	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000124	0.00291	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000123	0.00126	CcSEcCtD
Fludrocortisone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Fludrocortisone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—type 2 diabetes mellitus	0.00012	0.00283	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Fludrocortisone—Oedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000119	0.0028	CbGpPWpGaD
Fludrocortisone—Infection—Irbesartan—type 2 diabetes mellitus	0.000119	0.00122	CcSEcCtD
Fludrocortisone—Erythema—Ramipril—type 2 diabetes mellitus	0.000118	0.00122	CcSEcCtD
Fludrocortisone—Myalgia—Losartan—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000116	0.00274	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Fludrocortisone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000116	0.00272	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000113	0.00266	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000113	0.00265	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000113	0.00265	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Fludrocortisone—Oedema—Losartan—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—type 2 diabetes mellitus	0.000113	0.00265	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000112	0.00264	CbGpPWpGaD
Fludrocortisone—Infection—Losartan—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Fludrocortisone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000111	0.00261	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000111	0.0026	CbGpPWpGaD
Fludrocortisone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Fludrocortisone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000109	0.00113	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000109	0.00257	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Fludrocortisone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000108	0.00254	CbGpPWpGaD
Fludrocortisone—Desonide—NR3C1—type 2 diabetes mellitus	0.000106	0.0252	CrCbGaD
Fludrocortisone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000106	0.0252	CrCbGaD
Fludrocortisone—Vertigo—Ramipril—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000106	0.0025	CbGpPWpGaD
Fludrocortisone—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000105	0.00246	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Fludrocortisone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000104	0.0246	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000103	0.00243	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Fludrocortisone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Fludrocortisone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Fludrocortisone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000103	0.0243	CrCbGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000102	0.0024	CbGpPWpGaD
Fludrocortisone—Insomnia—Losartan—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Fludrocortisone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fludrocortisone—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fludrocortisone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fludrocortisone—AR—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000101	0.00237	CbGpPWpGaD
Fludrocortisone—Asthenia—Valsartan—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	9.93e-05	0.00234	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	9.92e-05	0.00233	CbGpPWpGaD
Fludrocortisone—Asthenia—Orlistat—type 2 diabetes mellitus	9.88e-05	0.00102	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—type 2 diabetes mellitus	9.83e-05	0.00231	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	9.74e-05	0.00229	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000994	CcSEcCtD
Fludrocortisone—Oedema—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000994	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	9.63e-05	0.00226	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	9.53e-05	0.0225	CrCbGaD
Fludrocortisone—Urticaria—Irbesartan—type 2 diabetes mellitus	9.52e-05	0.000979	CcSEcCtD
Fludrocortisone—Headache—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000978	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	9.42e-05	0.00221	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	9.38e-05	0.00221	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000961	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	9.34e-05	0.0022	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	9.3e-05	0.00219	CbGpPWpGaD
Fludrocortisone—Asthenia—Metformin—type 2 diabetes mellitus	9.11e-05	0.000937	CcSEcCtD
Fludrocortisone—Flurandrenolide—NR3C1—type 2 diabetes mellitus	9.09e-05	0.0215	CrCbGaD
Fludrocortisone—Testosterone Propionate—AR—type 2 diabetes mellitus	9.02e-05	0.0213	CrCbGaD
Fludrocortisone—Urticaria—Losartan—type 2 diabetes mellitus	8.96e-05	0.000921	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	8.94e-05	0.0021	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	8.87e-05	0.00209	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000908	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000906	CcSEcCtD
Fludrocortisone—Hydrocortamate—NR3C1—type 2 diabetes mellitus	8.79e-05	0.0208	CrCbGaD
Fludrocortisone—Insomnia—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000899	CcSEcCtD
Fludrocortisone—Headache—Valsartan—type 2 diabetes mellitus	8.73e-05	0.000898	CcSEcCtD
Fludrocortisone—Spironolactone—SHBG—type 2 diabetes mellitus	8.72e-05	0.0206	CrCbGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	8.67e-05	0.00204	CbGpPWpGaD
Fludrocortisone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	8.66e-05	0.0205	CrCbGaD
Fludrocortisone—Headache—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000888	CcSEcCtD
Fludrocortisone—Asthenia—Irbesartan—type 2 diabetes mellitus	8.6e-05	0.000884	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	8.59e-05	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	8.59e-05	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	8.59e-05	0.00202	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	8.53e-05	0.00201	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	8.44e-05	0.00199	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	8.42e-05	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	8.39e-05	0.00197	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—AR—type 2 diabetes mellitus	8.36e-05	0.0198	CrCbGaD
Fludrocortisone—Megestrol acetate—NR3C1—type 2 diabetes mellitus	8.34e-05	0.0197	CrCbGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	8.32e-05	0.00196	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.31e-05	0.000854	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	8.3e-05	0.00195	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	8.29e-05	0.00195	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	8.29e-05	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	8.23e-05	0.00194	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	8.18e-05	0.00192	CbGpPWpGaD
Fludrocortisone—Amcinonide—NR3C1—type 2 diabetes mellitus	8.18e-05	0.0193	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	8.18e-05	0.0193	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NCOA6—type 2 diabetes mellitus	8.17e-05	0.00192	CbGpPWpGaD
Fludrocortisone—Asthenia—Losartan—type 2 diabetes mellitus	8.09e-05	0.000832	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—AR—type 2 diabetes mellitus	8.01e-05	0.00188	CbGpPWpGaD
Fludrocortisone—Headache—Metformin—type 2 diabetes mellitus	7.95e-05	0.000818	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—type 2 diabetes mellitus	7.94e-05	0.00187	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—type 2 diabetes mellitus	7.91e-05	0.00186	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	7.87e-05	0.00185	CbGpPWpGaD
Fludrocortisone—Mometasone—NR3C1—type 2 diabetes mellitus	7.78e-05	0.0184	CrCbGaD
Fludrocortisone—Methyltestosterone—SHBG—type 2 diabetes mellitus	7.69e-05	0.0182	CrCbGaD
Fludrocortisone—Urticaria—Ramipril—type 2 diabetes mellitus	7.68e-05	0.00079	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	7.66e-05	0.0018	CbGpPWpGaD
Fludrocortisone—Spironolactone—AR—type 2 diabetes mellitus	7.65e-05	0.0181	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	7.64e-05	0.0018	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	7.54e-05	0.00177	CbGpPWpGaD
Fludrocortisone—Headache—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000772	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PIK3R1—type 2 diabetes mellitus	7.43e-05	0.00175	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	7.38e-05	0.00174	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	7.28e-05	0.00171	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	7.17e-05	0.017	CrCbGaD
Fludrocortisone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000733	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	7.12e-05	0.00167	CbGpPWpGaD
Fludrocortisone—Headache—Losartan—type 2 diabetes mellitus	7.06e-05	0.000726	CcSEcCtD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	7.05e-05	0.0167	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RELA—type 2 diabetes mellitus	6.99e-05	0.00164	CbGpPWpGaD
Fludrocortisone—Asthenia—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000713	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	6.9e-05	0.00162	CbGpPWpGaD
Fludrocortisone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	6.86e-05	0.0162	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	6.82e-05	0.0016	CbGpPWpGaD
Fludrocortisone—Spironolactone—ABCC2—type 2 diabetes mellitus	6.8e-05	0.0161	CrCbGaD
Fludrocortisone—Methyltestosterone—AR—type 2 diabetes mellitus	6.75e-05	0.016	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	6.73e-05	0.00158	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	6.71e-05	0.00158	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	6.68e-05	0.00157	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	6.67e-05	0.00157	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	6.63e-05	0.00156	CbGpPWpGaD
Fludrocortisone—Fluorometholone—NR3C1—type 2 diabetes mellitus	6.61e-05	0.0156	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	6.49e-05	0.00153	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	6.48e-05	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	6.48e-05	0.00152	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	6.39e-05	0.0151	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	6.36e-05	0.0015	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP11A1—type 2 diabetes mellitus	6.33e-05	0.015	CrCbGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	6.31e-05	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	6.29e-05	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	6.29e-05	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	6.21e-05	0.00146	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	6.13e-05	0.0145	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	6.07e-05	0.00143	CbGpPWpGaD
Fludrocortisone—Headache—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000623	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	6.05e-05	0.00142	CbGpPWpGaD
Fludrocortisone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	6.01e-05	0.0142	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	5.97e-05	0.0014	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	5.86e-05	0.00138	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	5.85e-05	0.00138	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—SHBG—type 2 diabetes mellitus	5.8e-05	0.0137	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	5.79e-05	0.00136	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	5.69e-05	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	5.68e-05	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	5.67e-05	0.00133	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	5.67e-05	0.0134	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	5.66e-05	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HNF4A—type 2 diabetes mellitus	5.56e-05	0.00131	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	5.55e-05	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—type 2 diabetes mellitus	5.49e-05	0.00129	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	5.48e-05	0.00129	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	5.46e-05	0.00128	CbGpPWpGaD
Fludrocortisone—Triamcinolone—NR3C1—type 2 diabetes mellitus	5.39e-05	0.0128	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	5.36e-05	0.00126	CbGpPWpGaD
Fludrocortisone—Spironolactone—NR3C1—type 2 diabetes mellitus	5.19e-05	0.0123	CrCbGaD
Fludrocortisone—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	5.1e-05	0.0121	CrCbGaD
Fludrocortisone—Dexamethasone—NOS2—type 2 diabetes mellitus	5.08e-05	0.012	CrCbGaD
Fludrocortisone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	5.02e-05	0.0119	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	5.02e-05	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	4.95e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	4.92e-05	0.00116	CbGpPWpGaD
Fludrocortisone—Prednisone—NR3C1—type 2 diabetes mellitus	4.89e-05	0.0116	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—PSMD6—type 2 diabetes mellitus	4.86e-05	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—DNMT1—type 2 diabetes mellitus	4.86e-05	0.00114	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	4.86e-05	0.0115	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	4.84e-05	0.00114	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—type 2 diabetes mellitus	4.81e-05	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	4.78e-05	0.00112	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CTGF—type 2 diabetes mellitus	4.77e-05	0.00112	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	4.74e-05	0.00112	CbGpPWpGaD
Fludrocortisone—Progesterone—SHBG—type 2 diabetes mellitus	4.72e-05	0.0112	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	4.68e-05	0.0011	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	4.62e-05	0.00109	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—type 2 diabetes mellitus	4.62e-05	0.00109	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	4.6e-05	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	4.59e-05	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	4.55e-05	0.00107	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	4.52e-05	0.00106	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	4.52e-05	0.00106	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	4.51e-05	0.00106	CbGpPWpGaD
Fludrocortisone—Prednisolone—NR3C1—type 2 diabetes mellitus	4.51e-05	0.0107	CrCbGaD
Fludrocortisone—Testosterone—SHBG—type 2 diabetes mellitus	4.46e-05	0.0106	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	4.45e-05	0.00105	CbGpPWpGaD
Fludrocortisone—Betamethasone—NR3C1—type 2 diabetes mellitus	4.41e-05	0.0104	CrCbGaD
Fludrocortisone—Eplerenone—CYP3A4—type 2 diabetes mellitus	4.41e-05	0.0104	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	4.36e-05	0.00102	CbGpPWpGaD
Fludrocortisone—Progesterone—AR—type 2 diabetes mellitus	4.14e-05	0.0098	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH2—type 2 diabetes mellitus	4.14e-05	0.000972	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	4.13e-05	0.000971	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	4.07e-05	0.000957	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.02e-05	0.000946	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	3.99e-05	0.000937	CbGpPWpGaD
Fludrocortisone—Testosterone—AR—type 2 diabetes mellitus	3.91e-05	0.00926	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.88e-05	0.000913	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.86e-05	0.000908	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AR—type 2 diabetes mellitus	3.86e-05	0.000907	CbGpPWpGaD
Fludrocortisone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	3.83e-05	0.00907	CrCbGaD
Fludrocortisone—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	3.79e-05	0.000891	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.76e-05	0.000885	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	3.71e-05	0.00877	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	3.69e-05	0.000867	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.68e-05	0.000866	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.55e-05	0.000836	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—type 2 diabetes mellitus	3.52e-05	0.000827	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.51e-05	0.000824	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	3.49e-05	0.000821	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	3.45e-05	0.00815	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.43e-05	0.000805	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.42e-05	0.000805	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.41e-05	0.000803	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	3.41e-05	0.000803	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	3.4e-05	0.0008	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCC2—type 2 diabetes mellitus	3.37e-05	0.00797	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.2e-05	0.000753	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	3.15e-05	0.000742	CbGpPWpGaD
Fludrocortisone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	3.12e-05	0.00739	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—type 2 diabetes mellitus	3.12e-05	0.000733	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.1e-05	0.00073	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—type 2 diabetes mellitus	3.06e-05	0.00724	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	3.05e-05	0.000718	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	3.02e-05	0.000711	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	3.01e-05	0.000707	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	3e-05	0.000705	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.98e-05	0.000701	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.93e-05	0.000688	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARA—type 2 diabetes mellitus	2.92e-05	0.000687	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.9e-05	0.000683	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	2.87e-05	0.000676	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	2.85e-05	0.000671	CbGpPWpGaD
Fludrocortisone—Prednisone—CYP3A4—type 2 diabetes mellitus	2.83e-05	0.0067	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	2.82e-05	0.000663	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	2.82e-05	0.00667	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.82e-05	0.000662	CbGpPWpGaD
Fludrocortisone—Progesterone—NR3C1—type 2 diabetes mellitus	2.81e-05	0.00664	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	2.79e-05	0.000657	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	2.77e-05	0.00065	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	2.75e-05	0.000647	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.67e-05	0.000627	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	2.65e-05	0.00628	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.61e-05	0.000615	CbGpPWpGaD
Fludrocortisone—Prednisolone—CYP3A4—type 2 diabetes mellitus	2.61e-05	0.00618	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	2.6e-05	0.000611	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	2.59e-05	0.000609	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	2.58e-05	0.000607	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	2.57e-05	0.000604	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—type 2 diabetes mellitus	2.57e-05	0.00608	CrCbGaD
Fludrocortisone—Betamethasone—CYP3A4—type 2 diabetes mellitus	2.56e-05	0.00605	CrCbGaD
Fludrocortisone—Betamethasone—PTGS2—type 2 diabetes mellitus	2.51e-05	0.00593	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.49e-05	0.000585	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—type 2 diabetes mellitus	2.47e-05	0.00585	CrCbGaD
Fludrocortisone—Progesterone—CYP1A2—type 2 diabetes mellitus	2.46e-05	0.00582	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—type 2 diabetes mellitus	2.42e-05	0.000568	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	2.36e-05	0.00559	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.36e-05	0.000555	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.33e-05	0.000548	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—type 2 diabetes mellitus	2.31e-05	0.00547	CrCbGaD
Fludrocortisone—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	2.26e-05	0.000531	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	2.26e-05	0.000531	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.24e-05	0.000526	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.22e-05	0.000522	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CTGF—type 2 diabetes mellitus	2.22e-05	0.000521	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.18e-05	0.000512	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.14e-05	0.000503	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.1e-05	0.000493	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.07e-05	0.000488	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2e-05	0.00473	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	1.96e-05	0.000461	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.92e-05	0.000451	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.85e-05	0.000436	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	1.79e-05	0.000421	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	1.77e-05	0.000415	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	1.71e-05	0.000403	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	1.71e-05	0.000403	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	1.68e-05	0.000395	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.65e-05	0.000388	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	1.63e-05	0.000384	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP3A4—type 2 diabetes mellitus	1.63e-05	0.00385	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.59e-05	0.000374	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP3A4—type 2 diabetes mellitus	1.54e-05	0.00364	CrCbGaD
Fludrocortisone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	1.49e-05	0.00352	CrCbGaD
Fludrocortisone—Dexamethasone—PTGS2—type 2 diabetes mellitus	1.46e-05	0.00345	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.46e-05	0.000342	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	1.45e-05	0.00034	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.44e-05	0.000339	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.36e-05	0.000319	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARA—type 2 diabetes mellitus	1.36e-05	0.000319	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—type 2 diabetes mellitus	1.34e-05	0.00318	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.25e-05	0.000294	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.24e-05	0.000291	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—type 2 diabetes mellitus	1.12e-05	0.000264	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.09e-05	0.000257	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.03e-05	0.000242	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.01e-05	0.000237	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—type 2 diabetes mellitus	9.55e-06	0.000225	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	8.5e-06	0.0002	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	7.66e-06	0.00018	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—type 2 diabetes mellitus	4.43e-06	0.000104	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	3.36e-06	7.91e-05	CbGpPWpGaD
